ischemic brain injury (Feuerstein et a!., 1997; Loddick and Rothwell, 1996; Minami et a!., 1992; Yamasaki et a!., 1995; Yamasaki et a!., 1992) , while administration or overexpression of IL-l receptor antagonists greatly re duces ischemic brain injury in rats and mice (Betz et aL, 1995; Garcia et a!., 1995; Relton et a!., 1996; Yang et a!., 1997) . IL-l [3 converting enzyme (ICE) cleaves proIL-1 [3 to IL-l [3, the biological active form. The observations that mice expressing a mutant ICE inhibiting protein or having the ICE gene knocked out, have reduced brain damage, further supports a crucial role for IL-l [3 during cerebral ischemia (Hara et a!., 1997 a; Schielke et a!., 1998) .
Similarly, tumor necrosis factor-alpha (TNF-a) ex pression is markedly increased after permanent and tem porary cerebral ischemia (Botchkina et a!., 1997; Pantoni et a!., 1998) . The action of TNF-a may worsen brain lllJury after ischemia (Buttini et a!., 1996; Liu et aI., 1994; Yang et aI., 1998) because administration of a TNF-a antagonist or soluble TNF-a receptor greatly re duces ischemic brain injury in rats and mice (Nawashiro et aI., 1997; Shohami et ai., 1996) . In contrast, Bruce et aI. (1996) reported that ischemic brain injury was in creased in mice genetically deficient in the TNF receptor, suggesting that TNF-a may have a neuroprotective func tion. However, TNF-a may play a primary role in "set ting the stage" for inflammatory and immune reactions elicited by cerebral ischemia (Feuerstein et aI., 1994) .
Although and TNF-a are implicated as media tors of ischemic brain injury in experimental models and in humans, the relationship between the release of IL-ll3 and TNF-a during cerebral ischemia is still unclear. Whether the actions of these two cytokines are indepen dent or whether the action of one cytokine is mediated by the other has yet to be determined.
Intercellular adhesion molecule-1 (ICAM-I) has been identified as a ligand for leukocyte adhesion molecules (Lindsberg et a!., 1996) , including LFA-I, Mac-I, and p 150, 95. There is increasing experimental evidence in vivo that the 132 integrins on leukocytes may be impor tant in the pathogenesis of inflammatory diseases (Chopp and Zhang, 1996) . The reaction of ICAM-I on the en dothelial cells is thought to facilitate lymphocyte migra tion and f inflammatory cell infiltration (Adams and Shaw, 1994) . Numerous reports suggest that ICAM-1 is upregu-1ated after various brain disorders, including cerebral ischemia, and inhibition of ICAM-I expression can re duce ischemic brain injury (Connolly et aI., 1996a; Handa et ai., 1995; lander et a!., 1995) . Recent studies show that infarct volume is significantly reduced in ICAM-1 knock out mice after cerebral ischemia and reperfusion (Soriano et a!., 1996; Soriano et ai., 1998) . Because IL-ll3 and TNF-a increase adhesion molecule expression in the endothelial cell cultures (Fabry et ai., 1992; McCarron et a!., 1994) , expression of these cyto kines in ischemic brain may be linked to tissue injury through ICAM -1 expression. This study was designed to identify (1) the time course of the expression of TNF-a after middle cerebral artery occlusion (MCAO) in mice deficient in the ICE gene (ICE KO) and wild-type (WT) mice; (2) the relationship between IL-ll3 deficiency and TNF-a expression after ischemic insult in these mice; and (3) the possible role of IL-ll3 and TNF-a in the regulation of ICAM-1 during cerebral ischemia.
MATERIALS AND METHODS

Animal preparation
Procedures for the use of laboratory animals have been ap proved by the institutional animal care and use committee. The ICE KO mice were created and characterized by the BASF Corporation, Worcester, MA (Li et a!., 1995) . These mice con-J Cereb Blood Flow Metab, Vol. 19, No. 10, 1999 tain a null mutation in the ICE gene (ICE-/-) generated by homologous recombination in embryonic stem cells. The wild type (WT, ICE+/+) mice were generated from the same chi meric founder, and interbred among themselves. Both strains have a mixed background of both SV129 and C57BLl6-derived genes.
Experimental groups
Ninety-four adult mice weighing 30 to 35 gm were used for three experiments: (I) ICE KO (n = 16) and WT (n = 16) mice underwent 3, 6, 12, and 24 hours of permanent MCAO (n = 4 at each time point). Two mice at each time point under went sham surgery. After the animals were killed by decapita tion, the brains were removed and prepared for TNF-a immu nohistochemistry.
(2) Thirty-two animals underwent a similar procedure with the brains being processed for ICAM-I immu nostaining. (3) ICE KO (n = 11) and WT (n = 11) mice underwent 3, 6, or 24 hours of MCAO or sham surgery, and were used to measure ICAM-l protein using immunoprecipi tation and Western blot analysis.
Middle cerebral artery occlusion
Adult ICE KO and WT mice were anesthetized with 4% isoflurane in 70%N20!30%02 and maintained at 1.5% isoflu rane delivered through a face mask. The body temperature was maintained with a heated blanket using a feedback control sys tem (73A, Yellow Springs, OH). The middle cerebral artery was permanently occluded for 3 to 24 hours in all groups of mice. Middle cerebral artery occlusion was performed as de scribed in our previous studies (Yang et aI., 1994) . Briefly, the left common carotid artery was exposed through a midline incision. The internal carotid artery was isolated and its branch, the pterygopalatine artery, was ligated close to its origin. A 2-cm length of 5-0 rounded tip nylon suture was gently ad vanced from the external carotid artery through the common carotid artery and then up to the internal carotid artery for a distance of 11.0 ± 0.5 mm.
CBF measurement
Surface blood flow was measured using a laser-Doppler flowmetry monitor (Model BPM2 System, Vasamedics Inc., St. Paul, MN, U.S.A.) equipped with a 0.7-mm diameter probe (P-433, Vasamedics). Blood flow was measured 5 minutes be fore and 15 minutes after MCAO at three points: (1) the isch emic core area: 3.5 mm lateral to the sagittal suture and 1 mm posterior to the coronal suture on the ipsilateral hemisphere; (2) the control area: 3.5 mm lateral to the sagittal suture on the contralateral hemisphere; and (3) the perifocal area: 1 mm lat eral to the sagittal suture on the ipsilateral hemisphere and 1 mm posterior to the coronal suture. Blood flow values are expressed as a percentage of baseline values.
TNF-a and ICAM-l immunohistochemistry
The mice were decapitated 3, 6, 12, and 24 hours after per manent MCAO, and the brains were removed and frozen im mediately in 2-methyl-butane solution (Mallinckrodt) at -40°C. Coronal cryostat sections (20-fLm thickness) were cut and mounted on precleaned Probe-on-slides (Fisher Scientific, Pittsburgh, PA). After drying, the sections were fixed with Cornoy fixative solution (60% methanol, 30% chloroform, and 10% acetate) for 20 minutes. Nonspecific binding was blocked by treatment with 10% normal goat serum for 30 minutes at room temperature. The sections were incubated in a 1: 100 di lution of poly clonal anti murine TNF-a primary antibody (Gen zyme, Cambridge, MA) overnight at 4°C. A negative control was performed using the same concentration of normal rat im-munoglobulin G instead of primary antibody. After treatment with 1 % H202 in 30%/70% methanol/phosphate-buffered sa line (PBS) solution, the sections were incubated with a bioti nylated goat antirabbit secondary antibody in I :200 dilution for 90 minutes at room temperature, followed by an ABC process (ABC-Elite Kit, Vector Lab., San Francisco, CA, U.S.A.). Fi nally, the sections were treated with stable DAB (Research Genetics, Huntsville, AL, U.S.A.) as a peroxidase substrate and counter-stained with hematoxylin. The same procedures were used for ICAM-I immunohistochemistry except for the use of 10% normal rabbit serum as a blocker of nonspecific binding, 1:300 dilution of rat monoclonal antimouse CDS4 as a primary antibody (Caltag, San Francisco, CA, U.S.A.), and biotinylated rabbit anti rat antibody (Vector Lab) as a secondary antibody.
The number of deep brown-stained TNF-a.-positive cells and ICAM-l-positive vessels from each mouse at each time point were counted in the three coronal sections located at +0.86, +0.38, -0.10 mm from Bregma. The immunopositive stained cells in the contralateral and the ipsilateral hemisphere were counted separately. The counting was performed manu ally to exclude the infiltrating cells occasionally expressing TNF-a and/or rCAM-I.
ICAM-l immunoprecipitation and Western blot analysis
Western blot analysis was performed to verify the reaction specificity of the ICAM-I antibody referred to above against mouse brain tissues. The mice were killed after 3, 6, and 24 hours of MCAO. Brains were immediately removed and di vided into contralateral cortex, contralateral basal ganglia, ip silateral cortex, and ipsilateral basal ganglia. The tissue samples were homogenized and lysed in a buffer containing ISO mmollL NaC!, 50 mmollL Tris-HCl, 1 % NP-40, 0.5% DOC, 0.1 % sodium dodecyl sulfate (SDS), and 100 f,Lg/mL polymethylsulfonylfluoride, as well as 2 f,Lg/mL each of pep statin, leupstatin, and chymostain. Lysates were cleared by cen trifugation at 14,000g for 10 minutes at 4°C. The protein con centration of each sample was determined with a Bio-Rad assay (Bio-Rad Laboratories, Hercules, CA, U.S.A.). ICAM-J pro tein was immunoprecipitated by the Harlow method (Harlow and Lane, 1988) . (1) Normal goat serum (10 f,LL) and protein AlG-sepharose-4B beads (20 f,LL) were applied to the superna tant and mixed for 120 minutes at 4°C. The nonspecific binding protein was discarded by centrifugation at 4000g for 10 min utes at 4°C. (2) Goat polyclonal rCAM-l antibody (1:100, Santa Cruz Biotechnology Inc., Santa Cruz, CA. U.S.A.) and the total protein extracted from the supernatant was added to the beads. The antigen-antibody-bead complex was rotated overnight at 4°C and washed in 100 mmollL PBS buffer. The target protein sample (10 f,LL) was dissociated from the com plex by 0.2% SDS solution. Western blot analysis was per formed using standard techniques (Sambrook et aI., 1989) . The sample was boiled at 100°C in SDS gel loading buffer (100 mmollL Tris-CI, 4% SDS, 0.2% bromophenol blue and 20% glycerol) for 5 minutes. The total protein sample was loaded onto a 7.5% SDS polyacrylamide gel. After electrophoresis, size-fractionated proteins were electrotransferred to a polyvi nylidene difluoride membrane (Bio-Rad Laboratories) in a transfer buffer. The membrane was placed in 5% powdered milk in Tween PBS (100 mmollL PBS solution with 0.1 % Tween 20) for 60 minutes at room temperature to block non specific binding. The transferred polyvinyJidene difluoride membrane was probed with polyclonal goat anti mouse ICAM-l antibody (Santa Cruz Biotechnology) I :500 in block ing buffer overnight at 4 DC. After washing in a solution of 0. 1 % Tween-20, 0.5% bovine albumin and I % nonfat dry milk three times for 10 minutes each, the membrane was immunoprobed with peroxidase-conjugated antigoat IgG-HRP (Santa Cruz Biotechnology) at I :2000. An enhanced chemiluminescence kit (Amersham, Buckinghamshire, England) was applied to detect the target protein ICAM-I. The membrane was wrapped in plastic wrap and exposed to Kodak film (X-omat AR, Eastman Kodak Company, Rochester, NY, U.S.A.). The film was devel oped according to the instructions of the manufacturer. Immuno reactivity for ICAM-I on each individual lane of the membrane was quantified by a gel densitometric scanning program using a National Institutes of Health 1.61 image analysis system.
Statistical analysis
Microcomputer-based statistical programs I Statview II (ABACUS, Berkeley, CA, U.S.A.) and Excel (Microsoft Cor poration)] were used for statistical analysis. All data are pre sented as mean ± standard deviation. Parametric data at differ ent time points during MCAO between the ICE KO and the WT mice were compared using analysis of variance followed by the Scheffe's test. A probability value of 0.05% was considered significant.
RESULTS
Physiologic parameters
Changes of body temperature in ICE KO and WT mice before and after MCAO were not significant at 3, 6, 12, and 24 hours of MCAO (P > .05). CBF in the isch emic core area decreased sharply to 16% to 20% and 16% to 22% of baseline 5 minutes after MCAO in the ICE KO and WT mice (Table 1 ). There were no signifi cant differences between the two groups at the various time points during MCAO (P > .05). The blood flow in the ipsilateral perifocal area decreased to 35% to 51 % and 37% to 49% in the ICE KO and the WT mice, respectively. Blood flow in the contralateral hemisphere in both groups remained at 93% to 1l7% and 101 % to 116% of the baseline flow during MCAO (Table 1) .
TNF -a immunohistochemistry
Little TNF-a. immunoreactivity was detected in brain sections from normal-and sham-operated mice. The negative control section (no anti-TNF-a. antibody) showed no brown staining. Few TNF-a.-positive stained cells were detected in either the sham-operated mice or in the contralateral hemisphere of the experimental ani mals after MCAO; however, TNF-a. immunopositive cells were observed in the ipsilateral hemisphere in the ICE KO and WT groups. The numbers of TNF-a. immu nopositive cells in the ICE KO and WT groups were not significantly different at any time point (P > .05). TNF-a.
immunoreactivity developed in the ischemic core area after 3 hours of MCAO, increased at 6 hours of MCAO, peaked at 12 hours of MCAO, and then subsided ( Figs.  1 and 2) . Most TNF-a.-positive cells were distributed in the ipsilateral cortical neuronal layer and displayed neu ronal morphology. TNF-a. immunoreactivity was also detected in the molecular layer of the hippocampus, the surrounding ventricles, the outer most layer of the core, and the corpus collosum of the ischemic hemisphere. WT, wild-type mice; ICE KO, interleukin-I i3 converting enzyme-deficient mice; Cont, contalateral hemi sphere; Core, ischemic core; perifocal, ischemic perifocal area. Values are mean ± SD for 6 mice at each time point.
ICAM-l immunohistochemistry
Increased expression of ICAM-l-positive vessels was observed in the ischemic c o re at 3 and 6 hours of MCAO; however, these ICAM-I-positive vessels were much more apparent in the perifocal area after 12 hours of There were few ICAM-l immunopositive vessels in either the sham-operated mice or in the contralateral hemisphere of the experimental animals after MCAO.
FIG. 1.
Photographs showing tumor necrosis lactor alpha (TNF-a) immunostaining in the ischemic core area in the mouse brain after 3 (A), 6 (8), 12 (C), and 24 hours (0) of middle cerebral artery occlusion in WT mice. Few TNF-a-positive stained cells were detected in brain sections from either sham-operated mice or the contralateral hemisphere in the mouse brain after middle cerebral artery occlusion (data not shown here) . Many positive TNF-a stained cells located in the ischemic cortex adjacent to the infarct region displayed highly intense TNF-a immunoreactivity. Some stained cells have long neural axon fragments that connect to the other TNF-a-positive cells, suggesting that the early synthesis of TNF-a protein may occur in the ischemic neurons and their axons. Bar = 30 j.Jm. MCAO. The negative control section showed no ICAM-l immunopositive staining. ICAM-l expression was significantly decreased in the ipsilateral hemisphere in the ICE KO mice compared to the WT mice ( Fig. 3) . Statistical analysis showed no significant differences in ICAM-I expression in the contralateral hemisphere be tween the two groups at different time points ( Fig. 4 , P > .05). As with TNF-a expression, lCAM-l expression increased in the ischemic hemisphere after 3 hours of MCAO, peaked at 12 hours (peaked at 12 hours in the WT mice), and decreased at 24 hours of MCAO. There were fewer ICAM-I-positive vessels in the ICE KO mice compared to the WT mice after 3, 6, 12, and 24 hours of MCAO (Fig. 4 , F = 3.5, df = 26, P < .05).
IeAM-! Western blotting analysis
Immunoprecipitation and Western blot analysis for ICAM-I detected a major band at approximately 90 kd in all samples tested. ICAM-I protein was present at a very low level in the sham-operated and contralateral hemi sphere after 3, 6, and 24 hours of permanent MCAO. ICAM-I protein expression was lower in the ipsilateral hemisphere in the ICE KO mice than in the WT mice after 3, 6, and 24 hours of permanent MCAO (Fig. 5) . However, statistical analysis shows that the decrease of ICAM-I protein expression is only significant at 24 hours after MCAO (P < .05).
DISCUSSION
This study shows that the adhesion molecule ICAM-I and the pro inflammatory cytokine, TNF-a, are expressed in ICE KO and WT mice after focal cerebral ischemia. However, in mice which are deficient in the ICE gene and not able to process proIL-II3, the expression of ICAM-I, but not TNF-a, was reduced. These findings suggest that after ischemia, ICAM-I expression is de pendent on IL-113 whereas the expression of TNF-a is independent of IL-II3. Considerable evidence points to ICAM-l as an important mediator of ischemic brain damage. Thus, reduced expression of this adhesion mol ecule may be one of the mechanisms through which ICE KO mice are protected during cerebral ischemia.
Gene knockout mice are useful tools for defining path ways leading to ischemic cell death (Huang et aI., 1994; Yang et aI., 1994) . In a previous study we showed that after permanent focal ischemia, ICE KO mice had less brain edema at 6 hours and smaller lesions at 24 hours compared to their WT controls (Schielke et aI., 1998) . This is in concert with studies showing that lesion size was reduced after MCAO in mutant mice expressing a dominant inhibitory ICE protein, or mice treated intra ventricularly with peptide ICE inhibitors (Hara et aI., I997a, b) . A possible mechanism underlying these obser vations is reduced IL-113 production by the ischemic brain. ICE is a member of the caspase family of cysteine proteases, which are associated with both proinflamma tory and apoptotic actions (Dinarello, 1992; Dinarello, 1996; Hara et aI., 1997 a; Schielke et aI., 1998) . Also known as caspase 1, ICE is critical for processing pro IL-I to the biologically active cytokine, IL-II3. Previous studies have shown that macrophages isolated from the ICE KO mice are not capable of producing IL-II3. Simi larly, in a model of endotoxic shock, no IL-113 is detected in the plasma of the ICE KO mice, and survival is greatly enhanced. IL-l a production is also reduced in these mice, although not to the extent of IL-113 (Dinarello, 1997) .
Recently studies have shown that pro-IL-I8 (also known as interferon-T inducing factor) is processed to its active form by ICE. IL-18, constitutively expressed in the rat brain, is structurally similar to lL-II3 (Culhane et aI., 1998) . In addition to stimulating the production of interferon-T, it may directly upregulate lCAM-I expres sion (Kohka et aI., 1998) . Although the role of IL-I8 in the ischemic brain has not been established, IL-I8 or other as yet unidentified ICE-dependent cytokines may contribute to the reduction in ischemic brain injury as shown in the ICE KO mice.
The physiologic mechanism underlying the reduction of brain injury in ischemic ICE KO mice should be con sidered. Our data showed that both the ICE KO and WT mice developed normally. The changes of surface CBF and body temperature in ICE KO and WT mice were not different during and after MCAO (Table 1) . Several stud ies showed the susceptibility to cerebral ischemia be tween different strains related to the structural and func tional differences in the patency of the circle of Willis (Barone et aI., 1993; Connolly et aI., 1996b) . Strains such as SV1129, commonly used to generate genetically modi fied mice, are resistant to cerebral ischemia as compared to C571BL6. Both the ICE KO and WT mice used in our study were derived from the same progenitors, a mixed SVI129 and C57/BL6 background. Thus, our result sug gests that the resistance to cerebral ischemia in the ICE KO mice is not likely to be due to the differences in strains or changes in cerebrovascular anatomy.
Inflammatory mechanisms have been implicated as important mediators of ischemic brain damage. IL-l [3 is (A, B) , 6 hours (C, 0), 12 hours (E, F), and 24 hours (G, H) of middle cerebral artery oc clusion (MCAO). The location shown here is the border zone between the infarct core and perifocal regions in the isch emic perifocal areas. There were few ICAM-1-positive stained vessels in either the sham control or the contralat eral hemisphere of the experi mental animals after MCAO (data not show here). How ever, the expression of ICAM-1-positive vessels in both ICE KO and WT mice were in creased at 3 hours after isch emia, peaked at 12 hours, and decreased after 24 hours MCAO. Bar = 301Jm. a cytokine that exerts an array of proinflammatory ac· tions, including induction of adhesion molecules, othel cytokines, chemokines, arachadonic acid, amyloid pre· cursor protein and nitric oxide (Betz et aI., 1996) . TNF-a has many of the same actions (Feuerstein et aI., 1994) . Expression of both IL-I [3 and TNF-a mRN As is upregu· lated after cerebral ischemia in rats (Wang et aI., 1994b) . The first evidence that IL-l [3 contributes the pathophysi· ology of stroke was the observation that intraventriculal injection of the endogenous IL-I receptor antagonist (IL· Ira) reduced the extent of ischemic damage after MCAO in rats (Relton and Rothwell, 1992) . This was confirmed in studies where IL-lra was administered intravenously or overexpressed in the brain using an adenoviral vectOl in a gene therapy approach (Betz et aI. , 1995) . In addi tion, IL-l [3 neutralizing antibody, administered intraven- There were few ICAM-1-immunopositive vessels in either the sham-operated or the contralateral hemisphere of the experimen tal animals, and there were no significant differences between the ICE KO and WT mice in these control hemispheres (P > .05).
ICAM-1-positive vessels in the ipsilateral hemisphere gradually increased from 6 hours, peaked at 12 hours (peaked at 6 hours in the WT mice), and decreased at 24 hours after MCAO. ICAM-1-immunopositive ,vessels in the ischemic hemisphere were sig nificantly less in the ICE KO mice than in the WT mice after MCAO (F = 11.2, df = 26, P < .05). Values are mean ± SD; N = 4 in each group; * P < .05 ICE KO group versus WT group mice.
tricularly, reduced brain edema after MCAO (Rothwell and Hopkins, 1995) . The studies of TNF-ex in stroke models have provided evidence that TNF-ex also contributes to ischemic brain damage, although apparently contradictory findings exist (Feuerstein et aI., 1994) . Direct administration of TNF-ex enhanced, and neutralizing antibodies to TNF-ex reduced the lesion size after MCAO (Yang et aI., 1998) . How ever, mice deficient in the TNF-ex receptor have larger lesion volumes after MCAO (Bruce et aI., 1996) .
The present study showed that the TNF-ex protein is expressed in the ischemic brain. It appeared in the isch emic core region 3 hours after MCAO and gradually increased at 6 hours, peaked at 12 hours, and then sub sided. This time course is similar to that of IL-I [3 mRNA expression described previously (Wang et aI., 1994h) . Studies have shown that TNF-ex mRNA and protein were expressed in ischemic rat brain, and the early expression was found in cells with a neuronal morphology. Buttini et al.(l996) identified a rapid upregulation of TNF-ex mRNA and protein in microglia and macrophages after ischemia in the rat. Furthermore, Siren et al. (1992) found that spontaneously hypertensive rats had higher levels of TNF-ex production in the brain as compared to normotensive rats. TNF-ex is produced by neurons, mi-croglial cells, macrophages, and astrocytes (Liu et aI., 1994; Medana et aI., 1997) . We have shown that TNF-ex protein was expressed in ischemic CD-l mice, and double labeled immunofluorescence localized the TNF-ex to neurons, astrocytes, and ependymal cells (Gong et aI., 1998) . The present study shows that TNF-ex can be pro duced in ICE KO mice, suggesting that TNF-ex produc tion is not dependent on IL-Ib.
ICAM-l is a member of the immunoglobulin family of adhesion molecules, which are expressed on the surface of endothelial cells. ICAM -I is important for establish ing adhesion of leukocytes before their movement across the endothelium into the tissue (Wang et aI., 1994a) . There is considerable evidence supporting the idea that leukocyte infiltration into the brain contributes to the development of the ischemic lesion. Blocking ICAM-l with an antibody reduces both neutrophil accumulation and the size of the lesion (Zhang et aI., 1994) . IL-I [3 and TNF-ex can induce ICAM-l expression in cultured endo thelial cells (Feuerstein et aI., ' 1997) . Endothelial cell adhesion molecules including ICAM-I, endothelial leu kocyte adhesion molecule-I, and P-selectin are important in establishing endothelial adhesion to the leukocyte be fore infiltration (Feuerstein et aI., 1997; Sharma and Ku mar, 1998 FIG. 5. Immunoprecipitation and Western blot analysis of inter cellular adhesion molecule-1 (ICAM-1) protein from the ipsilateral hemisphere of ischemic brain shows a band of ICAM-1 at 90 kd (upper). The immunoprecipitates were separated by sodium do decyl sulfate-polyacrylamide gel electrophoresis (7.5% acryl amide), transferred, blotted and detected by antibody and che miluminescence. ICAM-1 protein expression was lower in the ipsilateral hemisphere in the interleukin-1 f3 converting enzyme knockout (ICE KO) mice than in the wild-type (WT) mice after 3, 6, and 24 hours of permanent middle cerebral artery occlusion (MCAO) (upper). The bar graph shows optical density with equal amounts of isolated protein from the ipsilateral hemisphere in the ICE KO and the WT mice after 3, 6, and 24 hours of MCAO. (N = 3 in each group, lower). Values are mean ± SD; *P < .05, the ICE KO group versus the WT group mice.
TNF-a are known to be induced earlier than the adhesion molecules (Wang and Feuerstein, 1995) . IL-l [3 and TNF-a can induce ICAM-l, endothelial leukocyte adhe sion molecule-I, and P-selectin in vitro (Feuerstein et aI., 1997) . The development of an inflammatory response in focal ischemia, therefore, may appear in the following sequence: expression of IL-l [3 and TNF-a, upregulation of adhesion molecules, then migration of leukocytes. TNF-a mimics every known IL-l [3 action on endothelial cells. In our study, however, the expression of ICAM-l protein is significantly less in the ICE KO mice as com pared with WT mice after MCAO. This result suggests that mature IL-I [3 is a critical mediator in the upregula tion of ICAM-l expression during cerebral ischemia.
In summary, we showed that TNF-a was expressed after permanent MCAO in both the ICE KO and the WT mice, suggesting that the overexpression of TNF-a dur ing focal ischemia is not dependent on IL-l [3. The lower ICAM-l expression in the ICE KO mice suggests that IL-l [3 may play an important role in the upregulation of ICAM-l.
